Carfilzomib in relapsed or refractory multiple myeloma patients with early or late relapse following prior therapy: A subgroup analysis of the randomized phase 3 ASPIRE and ENDEAVOR trials
- Mateos, M.-V.
- Goldschmidt, H.
- San-Miguel, J.
- Mikhael, J.
- DeCosta, L.
- Zhou, L.
- Obreja, M.
- Blaedel, J.
- Szabo, Z.
- Leleu, X.
ISSN: 1099-1069, 0278-0232
Argitalpen urtea: 2018
Alea: 36
Zenbakia: 2
Orrialdeak: 463-470
Mota: Artikulua